These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37409991)

  • 1. Sex Differences in pLVAD-Assisted High-Risk Percutaneous Coronary Intervention: Insights From the PROTECT III Study.
    Shah T; Abu-Much A; Batchelor WB; Grines CL; Baron SJ; Zhou Z; Li Y; Maini AS; Redfors B; Hussain Y; Wollmuth JR; Basir MB; O'Neill WW; Lansky AJ
    JACC Cardiovasc Interv; 2023 Jul; 16(14):1721-1729. PubMed ID: 37409991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
    Abu-Much A; Grines CL; Chen S; Batchelor WB; Zhao D; Falah B; Maini AS; Redfors B; Bellumkonda L; Bharadwaj AS; Moses JW; Truesdell AG; Zhang Y; Zhou Z; Baron SJ; Lansky AJ; Basir MB; O'Neill WW; Cohen DJ
    Int J Cardiol; 2024 Dec; 417():132555. PubMed ID: 39270940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.
    Bharadwaj AS; Abu-Much A; Maini AS; Zhou Z; Li Y; Batchelor WB; Grines CL; Baron SJ; Redfors B; Lansky AJ; Basir MB; O'Neill WW
    Circ Cardiovasc Interv; 2024 Jul; 17(7):e013503. PubMed ID: 38708609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of anemia in patients undergoing PCI with Impella-support: insights from the PROTECT III study.
    Falah B; Redfors B; Zhao D; Bharadwaj AS; Basir MB; Thompson JB; Patel RAG; Schonning MJ; Abu-Much A; Zhang Y; Batchelor WB; Grines CL; O'Neill WW
    Front Cardiovasc Med; 2024; 11():1429900. PubMed ID: 39091353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI.
    Abu-Much A; Grines CL; Batchelor WB; Maini AS; Zhang Y; Redfors B; Bellumkonda L; Bharadwaj AS; Moses JW; Truesdell AG; Li Y; Baron SJ; Lansky AJ; Basir MB; Cohen DJ; O'Neill WW
    Am Heart J; 2024 Mar; 269():139-148. PubMed ID: 38151142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices.
    O'Neill WW; Anderson M; Burkhoff D; Grines CL; Kapur NK; Lansky AJ; Mannino S; McCabe JM; Alaswad K; Daggubati R; Wohns D; Meraj PM; Pinto DS; Popma JJ; Moses JW; Schreiber TL; Magnus Ohman E
    Am Heart J; 2022 Jun; 248():139-149. PubMed ID: 35192839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right Ventricular Dysfunction in Patients Undergoing High-Risk PCI with Impella.
    Rommel KP; Bonnet G; Bellumkonda L; Lansky AJ; Zhao D; Thompson JB; Zhang Y; Redfors B; Lurz PC; Granada JF; Bharadwaj AS; Basir MB; O'Neill WW; Burkhoff D
    J Card Fail; 2024 Oct; 30(10):1244-1254. PubMed ID: 39389734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Preprocedural SYNTAX Score With Outcomes in Impella-Assisted High-Risk Percutaneous Coronary Intervention.
    Medranda GA; Faraz HA; Thompson JB; Zhang Y; Bharadwaj AS; Osborn EA; Abu-Much A; Lansky AJ; Basir MB; Moses JW; O'Neill WW; Grines CL; Baron SJ
    J Soc Cardiovasc Angiogr Interv; 2024 Aug; 3(8):101981. PubMed ID: 39166169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Impact of short-time anticoagulant therapy after selective percutaneous intervention on prognosis of patients with coronary artery disease].
    Song Y; Tang XF; Xu JJ; Wang HH; Liu R; Jiang P; Jiang L; Gao LJ; Zhang Y; Song L; Xu LJ; Zhao XY; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):108-116. PubMed ID: 30818938
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
    Parasca CA; Head SJ; Milojevic M; Mack MJ; Serruys PW; Morice MC; Mohr FW; Feldman TE; Colombo A; Dawkins KD; Holmes DR; Kappetein PA;
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2493-2507. PubMed ID: 28007201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival.
    Meraj PM; Doshi R; Schreiber T; Maini B; O'Neill WW
    J Interv Cardiol; 2017 Jun; 30(3):256-263. PubMed ID: 28419573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
    Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and prognosis between male and female patients with premature coronary artery disease after intervention].
    Tang XF; Song Y; Xu JJ; Wang HH; Jiang L; Jiang P; Yao Y; Zhao XY; Gao Z; Yang YJ; Qiao SB; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):798-805. PubMed ID: 31648462
    [No Abstract]   [Full Text] [Related]  

  • 18. [Outcome of patients with coronary artery disease and left ventricular ejection fraction less than 50% undergoing percutaneous coronary intervention].
    Jiang L; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Gao LJ; Song L; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1058-1066. PubMed ID: 29325366
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention.
    Xu N; Tang XF; Yao Y; Jia SD; Liu Y; Zhao XY; Chen J; Gao Z; Yang YJ; Gao RL; Xu B; Yuan JQ
    Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):265-273. PubMed ID: 31740238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.